HEPCLUDEX 8.5 mg/1
BULEVIRTIDE · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Gilead Sciences, Inc.
Hepcludex (bulevirtide) is a prescription injection used to treat chronic hepatitis D infection in adults. It is given as a subcutaneous injection and works by blocking the entry of the hepatitis D virus into liver cells.
Key Facts
- Brand Name
- HEPCLUDEX
- Generic Name
- BULEVIRTIDE
- NDC Code (Product)
61958-3104- Manufacturer
- Gilead Sciences, Inc.
- Strength
- 8.5 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761468
- Marketing Start
- 05/22/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is HEPCLUDEX used for?
Hepcludex (bulevirtide) is a prescription injection used to treat chronic hepatitis D infection in adults. It is given as a subcutaneous injection and works by blocking the entry of the hepatitis D virus into liver cells.
Is HEPCLUDEX a controlled substance?
HEPCLUDEX is not classified as a controlled substance by the DEA.
What is the generic name for HEPCLUDEX?
The generic name for HEPCLUDEX is BULEVIRTIDE. There are no other listed brand versions of BULEVIRTIDE.
What is the NDC code for HEPCLUDEX 8.5 mg/1?
The NDC (National Drug Code) for HEPCLUDEX 8.5 mg/1 is 61958-3104, listed by Gilead Sciences, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)